Vaccination strategies in lymphoproliferative disorders: Failures and successes. Issue 10 (October 2015) - Allegra, A.
Highlights Anti-tumor vaccines hold out the prospect of effective tumor therapies. Lymphomas are weakly immunogenic. This prevent the recognition of tumor-associated antigens by cytotoxic T lymphocytes. We focus on the results of clinical trials of vaccination in lymphoma. We discuss potential strategies to enhance the efficacy of immunotherapy.